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1. Introduction 
According to the Rome ІІІ classification, functional gastroduodenal disorders (FGIDs) in 
adults are subdivided into six domains. Functional dyspepsia (FD) is a subcategory of the 
FGIDs. It is characterized by the presence of symptoms that are believed to be associated 
with gastroduodenal lesions, particularly epigastric pain or burning, postprandial fullness, 
or early satiation, without the evidence of organic disease to explain the onset of these 
symptoms at least 6 months before diagnosis (Tach J et al., 2006). Furthermore, FD is 
divided into 2 subtypes postprandial distress syndrome (PDS) and epigastric pain 
syndrome (EPS). The diagnostic criteria for PDS include the presence of 1 or both of the 
following symptoms several times in a week: bothersome postprandial fullness occurring 
after ordinary-sized meals, and early satiation that prevents finishing a regular meal. The 
diagnostic criteria for EPS include the presence of all of the following symptoms: 
moderately severe pain or burning localized to the epigastrium at least once per week, and 
intermittent pain, not generalized or localized to other abdominal or chest regions, not 
relieved by defecation or passage of flatus, and not fulfilling the criteria for gallbladder and 
sphincter of Oddi disorders. 
FD is a functional disorder that affects 10-30% of the population worldwide. The results of 
an Itarian population-based study, indicated that the prevalence rates of FD were 11%. Of 
these, PDS, EPS, and PDS accompanied with EPS were 67.5%, 48.2%, and 15.8% respectively 
(Zagari RM et al.,2010).The results of a Swedish population-based study, indicated that the 
prevalence rates of FD, PDS, EPS, and PDS accompanied with EPS were 15.7%, 12.2%, 5.5%, 
and 1.7%, respectively (Aro P et al., 2009). The results of a Norwegian population-based 
study, showed that the lifetime prevalence rate of FD was 23% in men and 18% in women 
(Johnsen et al., 1988), and that in the United States, was 29% (Shaib Y et al., 2004). 
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2. Pathogenesis and evaluation 
Different factors such as delayed gastric emptying (Stanghellini V et al., 1996; Sarnelli G et 
al., 2003), hypersensitivity to gastric distension (Bradette M et al., 1991; Mearin F et al., 1991; 
Barbera R et al., 1995; Tack J et al., 2001), impaired gastric accommodation to a meal (Tach J 
et al., 1998), abnormal duodenojejunal motility (Holtmann G et al., 1996; Wilmer A et al., 
1998), duodenal motor and sensory dysfunction (Samsom M et al., 1999; Schwarz MP et al., 
2001), duodenal hypersensitivity (Schwartz MP et al., 2001), Helicobacter pylori infection, and 
psychosocial factors have been implicated in the pathogenesis of FD. Among these factors, 
acid is thought to be more important because proton pump inhibitors (PPIs) and histamine 2 
(H2)-receptor antagonists have been proposed to be effective therapies for a subset of 
patients with FD. 
2.1 Duodenal hypersensitivity to acid in patients with FD 
Lee et al. (2004) reported that acid infusion into the duodenal bulb induced dyspepsia in 
healthy volunteers, and the symptoms of dyspepsia are more readily observed in patients 
with FD than in healthy subjects (Samsom et al., 1999). Increased duodenal acid exposure 
plays a role in the onset of dyspeptic symptoms in patients with FD having prominent 
nausea (Lee et al., 2004). A recent study indicated that acid infusion into the stomach 
predominantly induced dysmotility-like dyspeptic symptoms in healthy Japanese control 
subjects (Miwa et al., 2007). PPIs and H2-receptor antagonists have been proposed as 
effective therapies for treating FD (Delaney et al., 2005; Veldhuyzen van Zanten et al., 2005; 
Kinoshita et al., 2005; Seno et al. 2005). Guidelines for the management of dyspepsia suggest 
that PPI therapy is more effective than a placebo or H2-receptor antagonists in relieving the 
symptoms of patients with uninvestigated dyspepsia (Talley et al., 2005). 
2.2 Duodenal acid and gastroduodenal motility 
Duodenal acidification suppresses antral contractions. Matsunaga et al. (1994) reported that 
intragastric acidification and intraduodenal acidification at pH 1.0 inhibited spontaneous 
phase III activity in dogs. Simrén et al. (2003) reported that after acid infusion in healthy 
volunteers, antral contractions were lesser and the number of contractions in the proximal 
duodenum was greater than those before the infusion. It has been shown that the greater the 
concentration of acid in the duodenum, the greater is the inhibition of gastric emptying 
(Hunt et al., 1972). Duodenal pH influences interdigestive gastric motility in humans. 
Lowering of the duodenal pH prevents the occurrence of the gastric phase III (Woodtli et al., 
1995), and, in animals, duodenal acidification induces gastric relaxation by exerting an 
inhibitory effect on the stomach (Lu et al., 1999). Duodenal acidification has an inhibitory 
effect on gastric emptying (Danzer et al., 2004; Raybould et al., 1993; Cooke, 1974; Mearadji et 
al., 1999; Parkman et al., 1998), and hydrochloric acid (HCl) may restrict gastric outflow by 
inducing tonic occlusion of the duodenum (Parkman et al., 1998). 
2.3 Pathophysiological mechanism of acid-sensing system 
Visceral organs receive dual innervation from primary afferents commonly referred to as 
sympathetic afferents (splanchnic nerves) and parasympathetic afferents (vagus nerves). 
Lamb et al. (2003) reported that electromyographically recorded visceromotor responses 
increased after HCl administration in rats, but vagotomy and pretreatment with capsaicin 
abolished these responses. Their findings indicated that vagal pathways are involved in 
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mediating signals for the noxious stimulation of the stomach. Further, Scicho et al. (2005) 
reported that gastric acidification increased the expression of phosphorylated extracellular 
signal-regulated kinase-1 and -2 (p-ERK1/2) in the dorsal root ganglion neurons via N-
methyl-D-aspartate receptors. They suggested that sympathetic pathways are involved in 
mediating signals for noxious stimulation of the stomach. Noxious mechanical stimulation 
showed that most of the increased p-ERK1/2 neurons coexpressed transient receptor 
potential vanilloid receptor 1 and acid-sensing ion channel 3 (Sakurai et al., 2008). 
Transient receptor potential vanilloid receptor 1 and the acid-sensing ion channel 3 are 
largely involved in the acid-induced nociception in mammals (Ugawa et al., 2002), but it is 
still unknown which receptors of the peripheral sensory pathways encode and integrate an 
acidinduced nociceptive event in the gastric mucosa and the duodenal mucosa. Akiba et al. 
(2002) reported that the capsaicin pathway is an acid-sensing pathway that promotes 
hyperemia and mucus secretion in response to luminal acid in the duodenum. 
2.4 Method for evaluating duodenal hypersensitivity to acid and gastric motility 
Duodenal hypersensitivity to acid is one of the more important factors in the pathogenesis 
of FD. Although manometric methods, scintigraphic methods, electrogastrography and 
ultrasonography have been used to evaluate enterokinesis, a practical method for evaluating 
duodenal hypersensitivity to acid has not been reported. Transnasal endoscopy is a 
rescently developed, non-invasive and nondiscomforting method for examination of the 
upper gastrointestinal tract (Yagi et al., 2005; Murata et al., 2007). We developed a new 
method for evaluating duodenal hypersensitivity to acid and gastric motility by duodenal 
acidification using transnasal endoscopy (Ishii et al., 2008). 
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Fig. 1. *Number of antral contractions every two minutes; **Motility number; VAS: Visual 
Analogue Scale 
The study protocol is shown in Fig. 1. All subjects underwent transnasal endoscopy as 
required in the left lateral decubitus position in the morning after overnight fasting. The 
infusion of air into their stomachs was minimized in order to observe their gastric motility. 
An infusion tube (outer diameter 1.5 mm) was then introduced by transnasal endoscopy 
until the tip was located in the duodenal bulb. The subjects changed their body position to 
the supine position, and their antral contractions and dyspeptic symptoms were evaluated 
before and after a duodenal infusion of pure water (36.5°C, 100 ml) and acid (36.5°C, 0.1 N 
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HCl, 100 ml). The images of transnasal endoscopy were recorded from the beginning until 
the end on a DVD and were analyzed after finishing the examination. We infused 100 ml of 
pure water and acid at a rate of 20 ml/min. The use of an electronic infusion pump, ensured   
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Nausea or feeling sick
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Feeling that something is stuck in the throat 
Burning sensation in the chest 
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Fig. 2. 
 
Heavy feeling in the stomach
Nausea or feeling sick
Bloating
Belching
Cramping pain in the stomach
Dull pain in the stomach
Pricking pain in the stomach
Tickling or tingling in the throat
Sour or bitter taste
Feeling that something is stuck
in the throat 
Burning sensation in the chest
Pure Water0.1mol/L HCl
Maximum severity scale (cm)
(Mean±SEM)
Maximum severity on the 10 cm visual analogue scale after infusion
of 0.1 mol/L hydrochloric acid (HCl) or pure water (n=14)
Symptoms
P-value
0.0001
0.001
0.0006
0.2349
0.0016
0.0005
0.125
0.0539
0.0982
0.0932
0.0033
0.54±0.24
0.19±0.16
0.54±0.24
0.76±1.1
1.0±0.45
0.49±0.23
0.51±0.75
0.42±0.17
0.55±0.09
0.45±0.25
0.16±0.1
4.76±0.74
4.65±1.1
3.66±0.8
1.61±0.61
2.67±0.75
3.39±0.88
4.05±0.83
1.58±0.72
2.35±0.91
1.1±0.16
1.6±0.64
 
Table 1. 
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that the subjects were blinded to the nature (acid or pure water) of the infusion. The acid 
infusion was started 5 min after the infusion of pure water was finished. The severity of 
each symptom was assessed by each subject using a 10-cm visual analogue scale every 2 min 
(Fig. 2). The symptoms assessed were as follows: a heavy feeling in the stomach, bloating, 
nausea or feeling sick, belching, a dull pain in the stomach, cramping pain in the stomach, a 
pricking pain in the stomach, tickling or tingling sensation in the throat, a sour or bitter 
taste, a feeling that something is stuck in the throat, and a burning sensation in the chest. 
The symptom severity scales were set at 0 cm before the duodenal infusion of water and 
acid. The maximum severity scale was calculated as the mean of the individual maximum 
values. We evaluated the differences between the maximum severity scales in the infusion 
of pure water and acid. Antral contractions beginning every 2 min before the duodenal 
infusion of water were counted every 2 min until the end of the examination. The 
macroscopic waves of gastric peristalsis propagating from the gastric body to the antrum 
were counted. The motility number was defined as the mean number of antral contractions 
in 1 min. We evaluated the differences between the motility numbers before and after the 
infusion of pure water and those before and after acid infusion. We compared the changes 
in the symptom severity scales, the maximum severity scales of each subject, the number of 
antral contractions, and the motility number between the acid and pure water infusion. 
Using this method, we showed that the maximum severity scale of a heavy feeling in the 
stomach, and other symptoms was significantly greater after the acid infusion than that the 
pure water infusion in healthy volunteers (Table 1). During pure water infusion, no changes 
were observed between the motility numbers. On the other hand, the motility number 
significantly decreased after duodenal acidification (before vs. after: 2.93 ± 0.12 times vs. 1.11 
± 0.23 times, P<0.0001) (Fig. 3). 
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Fig. 3. 
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Furthermore, using this method we evaluated duodenal hypersensitivity to acid in healthy 
volunteers and patients with FD (Ishii et al., 2010). The study protocol is shown in Fig. 4. In 
this study, we infused the patients with 20 ml of HCl at a rate of 20 ml/min. The severity of 
12 symptoms was assessed by each subject using a 100-mm visual analogue scale (VAS) 
from the time acid infusion was started up to 30 min after the initiation of the infusion. 
 
Protocol
Acid
0 1 20 30
VAS VAS VAS VAS VAS VAS 
6 10 152
Time(min)
 
Fig. 4. Study protocols. This study consisted of monitoring of the assessment of symptoms 
using VAS 
 
Heavy feeling in the stomach
Nausea or feeling sick
Bloating
Belching
Cramping pain in the stomach
Dull pain in the stomach
Prickling pain in the stomach
Tickling or tingling in the throat
Sour or bitter taste
Feeling that something is stuck
in the throat 
Burning sensation in the chest
Early satiety
Patients with
FD
Healthy
volunteers
Maximum severity scale (mm)
(Mean±SEM)
Maximum severity on the 100-mm visual analogue scale after infusion of 0.1 mol/L 
hydrochloric acid (HCl) between healthy volunteers and patients with FD.
*P < 0.05, 2-sided non-paired t test
Symptoms
P-value
<0.001
0.036
<0.001
0.254
0.017
0.003
0.084
0.008
0.011
<0.001
0.073
5.9±2.0
4.4±1.9
14±3.5
9.6±6.3
4.5±2.3
4.8±2.2
0.6±0.6
0.6±0.6
1.9±1.1
3.1±2.0
25.5±4.4
14.4±4.3
39.1±5.1
20.0±4.9
10.6±3.6
19.4±5.0
21.8±5.0
12.9±4.1
9.7±3.2
8.9±3.1
18.6±4.3
35.6±5.3 9.0±3.9 <0.001
5.4±2.7
*
*
*
*
*
*
*
*
*
 
Table 2. Maximum severity scales between healthy volunteers and patients with FD 
The maximum severity scale was defined as the maximum score of the symptom severity 
scale. The VAS was set at 0 mm just before the duodenal infusion of acid. The total score 
was defined as the aggregate score of the maximum severity scale for the 12 symptoms.  
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The differences in the rate of incidence of dyspeptic symptoms, maximum severity scales, 
and total scores between patients with FD and healthy volunteers were evaluated.  
The rates of dyspeptic symptoms in patients with FD and healthy volunteers after acid 
infusion were 88.6% and 75%, respectively (P = not significant, using the Χ2-test). The 
maximum severity scales of a heavy feeling in the stomach, nausea or feeling sick, bloating, 
cramping pain in the stomach, dull pain in the stomach, tickling or tingling in the throat, 
sour or bitter taste, feeling that something is stuck in the throat and early satiety 
significantly increased after acid infusion in patients with FD than in healthy volunteers (P < 
0.05, using the two-sided non-paired t-test) (Table 2). There were significant differences in 
the total scores (patients with FD vs healthy volunteers: 233.8 ± 37.8 vs 63.9 ± 14.6; P < 0.001, 
using the two-sided nonpaired t-test) (Fig. 5). We found that duodenal acidification induced 
dyspeptic symptoms more significantly in patients with FD than in healthy volunteers. 
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Fig. 5. 
3. Conclusion 
The effects of duodenal acidification by transnasal endoscopy significantly increased 
various dyspeptic symptoms not suppresses this symptoms. Further, this method enabled 
the evaluation of duodenal hypersensitivity to acid in healthy volunteers and in patients 
with FD. Using this method, we might be able to clarify a correlation between duodenal 
hypersensitivity to acid and the effectiveness of PPI therapy for the treatment of FD. A 
further examination is needed. 
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Endoscopy has had a major impact in the development of modern gastroenterology. By using different data it
provided a better understanding of pathogenic mechanisms, described new entities and changed diagnostic
and therapeutic strategies. Meanwhile, taking advantage of many technical advances, endoscopy has had a
developed spectacularly. Video-endoscopes, magnification, confocal and narrow-band imaging endoscopes,
endoscopic ultrasounds and enteroscopes emerged. Moreover, endoscopy has surpassed its function as an
examination tool and it became a rapid and efficient therapeutic tool of low invasiveness. InTech Open Access
Publisher selected several known names from all continents and countries with different levels of development.
Multiple specific points of view, with respect to different origins of the authors were presented together with
various topics regarding diagnostic or therapeutic endoscopy. This book represents a valuable tool for
formation and continuous medical education in endoscopy considering the performances or technical
possibilities in different parts of the world.
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